Yifeng Pharmacy Chain Co., Ltd. (SHA:603939)
25.76
-0.42 (-1.60%)
Sep 12, 2025, 3:00 PM CST
Yifeng Pharmacy Chain Revenue
Yifeng Pharmacy Chain had revenue of 5.71B CNY in the quarter ending June 30, 2025, a decrease of -1.36%. This brings the company's revenue in the last twelve months to 24.02B, up 1.60% year-over-year. In the year 2024, Yifeng Pharmacy Chain had annual revenue of 24.06B with 6.53% growth.
Revenue (ttm)
24.02B
Revenue Growth
+1.60%
P/S Ratio
1.30
Revenue / Employee
600.27K
Employees
40,018
Market Cap
31.23B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 24.06B | 1.47B | 6.53% |
Dec 31, 2023 | 22.59B | 2.70B | 13.59% |
Dec 31, 2022 | 19.89B | 4.56B | 29.75% |
Dec 31, 2021 | 15.33B | 2.18B | 16.60% |
Dec 31, 2020 | 13.14B | 2.87B | 27.91% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Shanghai United Imaging Healthcare | 10.98B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Aier Eye Hospital Group | 21.94B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |